Statistics
Publications
56
Citations
2.9K
H-Index
29
Active since
1985
Shu Xing is an author at Jilin University specializing in life sciences, pharmacology, and protein tyrosine phosphatase inhibitors.
Publications per year
1985–2025
56
56
Identification of an Acquired JAK2 Mutation in Polycythemia Vera
Runxiang Zhao, Shu Xing, Zhe Li et al. · Journal of Biological Chemistry · 2005 · 617 citations · Full text
Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice
Shu Xing, Tina Ho Wanting, Wanming Zhao et al. · Blood · 2008 · 211 citations · Full text
JAK2V617F: prevalence in a large Chinese hospital population
Xuesong Xu, Qi Zhang, Jian Luo et al. · Blood · 2006 · 141 citations · Full text
Erlotinib Effectively Inhibits JAK2V617F Activity and Polycythemia Vera Cell Growth
Zhe Li, Mingjiang Xu, Shu Xing et al. · Journal of Biological Chemistry · 2006 · 122 citations · Full text
Medicine, Hematology, Pharmacology +15
Pan Fu, Shu Xing, Mengjia Xu et al. · Sensors and Actuators B Chemical · 2019 · 113 citations
1–5 of 56